Long-Term Outcomes with Arteriovenous Fistulas in a Pediatric Population  by Wartman, Sarah M. et al.
JOURNAL OF VASCULAR SURGERY
566 Abstracts August 2013not known. We sought to determine if cardiogenic emboli have a random
distribution or if there are factors that predict site of embolization, limb
salvage and mortality.
Methods: Upper (UE) and lower extremity (LE) emboli were evalu-
ated over a 6 year period. Demographic (age, gender, smoking, medical
comorbidities) and echocardiographic data were analyzed to determine
predictors of embolic site. All patients underwent surgical revascularization.
Limb salvage and mortality were compared with Kaplan-Meier analysis.
Results: 160 patients (72 male, 88 female) with presumed cardiogenic
emboli were identiﬁed, 56 UE (35 right, 21 left) and 104 LE (42 right, 44
left, 18 bilateral). Men had signiﬁcantly higher LE emboli than females
(76% vs 56%) and females more UE (44% vs 24%; P ¼ .01). No other demo-
graphic factors were statistically different. UE patients were more likely to
have atrial ﬁbrillation on admission (50% vs. 30%; P ¼ .04), while there was
a trend towards LE patients having a higher percentage of aortic or mitral
valvular disease (47% vs 31%; P ¼ .06). 30 day limb salvage was higher for
UE compared to LE (100% vs 88%; P ¼ .008) There was a trend toward
higher 30 day mortality in the LE group (14% vs 5%; P ¼ .08). One year
mortality in both groups was approximately 25%.
Conclusions: UE emboli are more frequent in women and patients
with active atrial ﬁbrillation. LE emboli are more frequent in men and
patients with valvular disease, and are associated with increased 30 day
limb loss and mortality. These ﬁndings suggest gender- and cardiac-speciﬁc
differences in patterns of blood ﬂow leading to preferential sites of periph-
eral embolization.
Beyond Arterial Stenosis: Walking Disability in PAD Patients Is
Related to Arterial Endothelial Function
Christopher D. Owens, Hugh F. Alley, Karen C. Chong, Jade S. Hiramoto,
Michael S. Conte, Joseph H. Rapp, Marlene S. Grenon. University of
California, San Francisco, San Francisco, Calif
Objectives: Patients with peripheral artery disease (PAD) have varying
degrees of walking disability that do not completely correlate with ankle
brachial index (ABI) or angiographic anatomy. We hypothesized that endo-
thelial function (EF) is an independent predictor of symptom severity in
PAD patients.
Methods: This was a prospective cohort study of PAD patients
(n ¼ 100) presenting to a vascular surgery clinic. All patients received ABIs
and brachial artery ﬂow-mediated, endothelium-dependent, vasodilation
(FMD) to assess arterial EF. PAD severity was assessed by the clinical Ruth-
erford score. Demographic, biochemical and physiologic parameters were
entered into regression equations to determine association with disease
severity.
Results: Mean age was 66.3 6 8.2 and 43% had diabetes. Mean FMD
was 7.3% indicating impaired EF. EF progressively declined as Rutherford
score increased (P < .0001). Diabetes mellitus, albumin, CRP, homocys-
teine, total cholesterol, and hgbA1c, were all associated with Rutherford
score (all P < .05). After multivariable regression, EF (P < .0001), ABI
(P < .0001), and total cholesterol (P ¼ .033) were predictive of walking
disability. Combined, EF, ABI, and total cholesterol account for 50% of the
variability in Rutherford scores. However EF and ABI were not correlated
indicating that they are independent predictors of disability. When the cohort
was restricted to claudicants (n ¼ 81), EF was equally predictive of walking
disability. Homocysteine was inversely associated with EF (P ¼ .024).
Patients with hyperhomocysteinemia (>15 mmol/L; n ¼ 41) had lower EF
(P ¼ .04) and higher Rutherford scores (P ¼ .017) than those without.
Conclusion: Symptom severity in PAD is multifactorial, reﬂecting
both impaired hemodynamics and vascular dysfunction. This is the ﬁrst
demonstration that walking disability in PAD is associated with arterial
EF. Endothelial dysfunction in this cohort may be related to homocys-
teine-dependent mechanisms by reducing bioavailable nitric oxide.
Prospective Evaluation of Tissue Perfusion in Patients with Peripheral
Arterial Disease Using Laser-Assisted Fluorescent Angiography
Venita Chandra, MD, Mohamed Zayed, MD, PhD, Elizabeth
Hitchner, MS, Vinit N. Varu, MD, Oliver Aalami, MD, Wei Zhou, MD.
Vascular Surgery, Stanford University Medical Center, Stanford, Calif
Objectives: Laser-assisted ﬂuorescent angiography (LAFA) has been
used by many specialties to evaluate end organ tissue perfusion. We hypoth-
esize that LAFA can be a valuable tool to qualitatively and quantitatively
assess distal perfusion in patients with peripheral arterial disease (PAD).
Using this technology we prospectively evaluated PAD patients pre- and
postvascular interventions.
Methods: Patients undergoing interventions for PAD were prospec-
tively recruited into this IRB approved pilot study. Plantar pedal perfusion
was analyzed pre- and postvascular intervention using the SPY Elite
LAFA system (Lifecell Corporation). Topographical and ﬂuorescentimages were obtained for each patient pre- and postvascular intervention
(Fig). Peak pedal perfusion and ingress slope (rate of inﬂow) were derived
from the recorded images. Ankle brachial indices (ABIs) were also evaluated
pre- and postintervention. Statistical analysis was performed using Student’s
t-test and Pearson correlation.
Results: Twenty-seven patients with PAD comprised the study pop-
ulation, with an average age of 68. The majority of patients had Ruther-
ford class 5 critical limb ischemia (55%) and one vessel tibial runoff
(61%). The majority of patients underwent endovascular femoral and
popliteal interventions (88%). Postintervention signiﬁcant increases were
seen in pedal ﬂuorescent ingress slopes (P ¼ .03) and a similar increase
in ABIs (P ¼ .001). Peak pedal perfusions increased in 66% of patients
by an average of 45.8%. Both peak pedal perfusion and ingress slope corre-
lated with postintervention ABI (R2¼.56 and R2¼.58, respectively). Peak
pedal perfusion and ingress slope also demonstrated a moderate correla-
tion (R2¼.75).
Conclusions: This prospective pilot study demonstrates feasibility and
utility of LAFA in the perioperative evaluation of PAD patients. Qualitative
and quantitative ﬂuorescent images provide real-time and objective assess-
ments of pedal tissue perfusion. LAFA-derived peak pedal perfusion and
ingress slope provide objective measurements of tissue perfusion that corre-
late with conventional methods using ABIs. With further study, we antici-
pate that this technology may be a helpful adjunct for intraoperative
decision making and predicting wound healing capacity.
Superﬁcialization of the Brachial Artery: An Appraisal of Its Value for
Vascular Access
Takashi Nakamura, MD,1 Junichi Nakamura, MD2. 1Osaka Rosai Hospital,
Sakai, Osaka, Japan; 2Tenma Nakamura Clinic, Osaka, Japan
Objectives: The Japanese Society for Dialysis Therapy recommends
superﬁcialization of the brachial artery (BA) as an alternative vascular access
(VA) technique in patients for whom a conventional internal shunt (AVF or
AVG) cannot be created. Although 2-3% of Japanese hemodialysis patients
undergo this procedure, it is not well recognized worldwide. We report here
our experience with the procedure, as well as indications, durability, and
morbidity.
Method: The technique involves exposure of the BA and ligation of
the side branches, then ﬁxing it beneath the skin at the upper arm. Cannu-
lation of the BA is performed 2 weeks or more after surgery and it is used as
an outﬂow route, with any vein in an upper extremity utilized for blood
return, including the hand if sites in the arm are not accessible. We retro-
spectively reviewed our cases of superﬁcialization of the BA for VA.
Results: From 2005-2008, a total of 24 patients (11 females [46%],
average age 69 years [range, 39-84 years]) underwent superﬁcialization of
the BA, of whom 8 (33%) had diabetes. The indications were (1) impaired
cardiac function (n ¼ 13), (2) no other prospect for AVF or patient refused
prosthetic graft implantation (n ¼ 5), (3) severe upper extremity arterial
disease or ischemic steal syndrome requiring AVF closure (n ¼ 3), (4)
venous hypertension with central vein occlusion (n ¼ 2), and (5) repeated
AVF thrombosis due to heparin-induced thrombocytopenia (n ¼ 1). The
mean follow-up period was 28 months. Serious complications were seen
in 1 patient with an infected pseudoaneurysm formation associated with
a BA puncture, which necessitated BA ligation, while we also had difﬁculty
ﬁnding a vein for blood return in 5 patients. The rate of superﬁcialized BA
patency as a functioning VA was 95% and 66% at 1 and 3 years, respectively.
Conclusions: Superﬁcialization of the BA was found to be a simple
and safe technique, with acceptable durability and complication rate in
selected Japanese hemodialysis patients. We consider that this shuntless
VA permits adequate blood ﬂow and has theoretical advantages for some
patients, particularly those with impaired cardiac function, though the avail-
ability of a return vein is a prerequisite for a functioning VA.
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Objectives: Kidney Disease Outcome Quality Initiative guidelines
recommend permanent access in dialysis patients aged 0-19 who are greater
than 20kg and unlikely to be transplanted within one year. Unfortunately,
greater than 80% of these patients currently dialyze through a permanent
catheter and are exposed to the associated risks and shortcomings. With
a clear imperative to increase the incident use of permanent access in pedi-
atric patients, our objective is to examine the long-term outcomes of pedi-
atric arteriovenous ﬁstulas (AVF).
Methods: An updated retrospective review was performed of all arte-
riovenous ﬁstulas created in a hemodialysis population aged 0-19 at a single
institution from 1999 to 2012. Data abstracted included age, weight,
etiology of renal failure, time on dialysis, central venous catheter history,
and transplantation history. Data was analyzed to determine the inﬂuence
of these variables on primary and secondary patency.
Results: A total of 101 AVF in 93 patients were performed during
the study period. Mean age was 14 years (range, 3-19 years), 65 patients
(70%) were male, and mean weight was 51kg (range, 12-131 kg). Sixty-
six patients (82%) were already on hemodialysis at the time of ﬁstula crea-
tion, with a mean length of dialysis dependence of 18 months. At the time
of surgery, 78% of patients had a previous central venous catheter, and 24%
had 2 or more catheters. 43 radiocephalic ﬁstulas, 29 brachiocephalic
ﬁstulas, 20 basilic vein transpositions, and 9 femoral vein transpositions
were performed. Mean follow-up was 2.5 years. Two-year and 4-year
primary and secondary patency rates were 83% and 92%, and 65% and
83%, respectively. Increasing age was correlated with improved primary
patency (P ¼ .02), but had no impact on secondary patency. Weight,Table.
Subject
Acute
or chronic
Type of rib resection
and reconstruction Post-op complication LOS post FRR
1 Acute FRR, infraclavicular Thrombosed axillary-subclavian vein 4
2 Acute FRR, infraclavicular, partial sternotomy,
patch venoplasty
Hemothorax post op 4
3 Acute FRR, infraclavicular, partial sternotomy
patch venoplasty
Readmission for L apical extrapleural
hematoma, chest tube insertion
2
4 Acute FRR, transaxillary Readmission for R hemothorax, pigtail
catheter
3
5 Acute FRR, infraclavicular, repair of prox subclavian
vein using patch venoplasty
Readmission after ﬁrst thrombolysis/
thrombectomy for recurrent DVT
8
6 Acute FRR, infraclavicular, repair
of subclavian vein using patch venoplasty
Subdermal hematoma, bedside drainage 2
7 Acute FRR, infraclavicular, repair of prox subclavian
vein using patch venoplasty
Intra and extrapleural hematoma post op 8
8 Acute Medial claviculectomy, subclavian vein resec-
tion, IJ turn down w anastomosis
None 7
9 Acute FRR, transaxillary None 1
10 Acute FRR infraclavicular, repair of prox subclavian
vein using patch venoplasty
None 6
11 Acute FRR, infraclavicular, repair of prox subclavian
vein using patch venoplasty
None 2
12 Chronic FRR, infraclavicular, intraop venogram None 1
13 Chronic FRR infraclavicular None 1
14 Chronic FRR, infraclavicular, repair of subclavian vein
using patch venoplasty
Readmission for chest wall hematoma, and
thrombosed subclavian vein,
GSV harvest site hematoma
3
15 Chronic FRR supraclavicular and infraclavicular None 3
16 Chronic FRR, transaxillary None 2
17 Chronic FRR transaxillary 3/31/08, venogram and
balloon angioplasty subclavian vein 5/30/
08
None 1
18 Chronic FRR transaxillary 8/4/08, venogram 8/25/
08
None 1
19 Chronic NO RIB RESECTION performed due to
negative venogram
None
20 Chronic FRR, infraclavicular, repair of prox subclavian
vein using patch venoplasty
None 3
21 Chronic FRR, infraclavicular, repair of prox subclavian
vein using patch venoplasty
None 1
22 Chronic FRR infraclavicular, axillary subclavian
replacement with interposition femoral vein
graft
Readmission for thrombosed interposition
vein graft
4etiology, catheter location and catheter history were not signiﬁcantly asso-
ciated with primary or secondary patency. Sixty-eight patients (75%)
received a renal transplant in the postoperative period, with a mean time
to transplant of 556 days.
Conclusions: Arteriovenous ﬁstula creation is indicated in the pedi-
atric hemodialysis population and provides favorable long-term patency
rates. Although time to transplant is shorter for pediatric patients, focused
efforts should be made to mirror the Fistula First success in the adult
population.
Thoracic Outlet Syndrome in High-Performance Athletes
Venita Chandra, MD, Benjamin Colvard, MD, Christine Little, Cornelius
Olcott, IV, MD, Jason T. Lee, MD. Vascular Surgery, Stanford
University Medical Center, Stanford, Calif
Objectives: Repetitive upper extremity use in high performance
athletes is associated with the development of neurogenic and vascular
TOS. Surgical therapy in appropriately selected patients can provide relief
of symptoms and protection from future disability. We sought to determine
whether athletes treated for TOS can return to their prior high performance
level.
Methods: We reviewed competitive athletes treated for venous or
neurogenic TOS from 2000-2012. Patient demographics, workup, and treat-
ment approaches were analyzed. nTOS patients were assessed with quality
of life surveys using the previously validated mini-QuickDASH (QD) scale
(0-100, 100¼worse). Return to full athletic activity was deﬁned as returning
to prior competitive high school, collegiate, or professional sports.
Results: Thirty-eight competitive athletes (mean age, 21; 45% female)
were treated during the study period; 12 baseball players, 11 swimmers, 5
